Unique ID issued by UMIN | UMIN000028272 |
---|---|
Receipt number | R000032366 |
Scientific Title | Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode. |
Date of disclosure of the study information | 2018/01/01 |
Last modified on | 2018/10/09 13:08:46 |
Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.
AAA study
Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.
AAA study
Japan |
febrile seizure
Medicine in general | Pediatrics | Child |
Others
NO
The aim of this study is to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.
Efficacy
The outcome is the recurrece of febrile seizure in the same fever episode.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
Numbered container method
2
Prevention
Medicine |
rectal acetaminophen (10mg/ kg) every 6 hours until 24 hours after the onset of febrile seizure
without any other antipyretic 24 hours after febrile seizure
6 | months-old | <= |
72 | months-old | >= |
Male and Female
Children and infants who come to emergency room of Hirakata City Hospital with febrile seizures between May 1, 2015, and April 30, 2018, were considered for inclusion in the study.
1)Patients with seizure over 15 minutes were excluded from the study as status epilepticus.
2)Patients with diarrhea were excluded because it is difficult to put suppositories and other pathologies may be involved such as convulsion with mild gastroenteritis .
3)Patients with epilepsy, chromosomal abnormality, inherited metabolic diseases, brain tumor, cerebral hemorrhage, hydrocephalus, and those with a history of intracranial surgery were excluded.
4)Patients who were used to prevent febrile seizuress with diazepam suppository were excluded.
5)Patients take antihistamine that may increase seizure susceptibility in patients with febrile seizures were also excluded.
500
1st name | |
Middle name | |
Last name | Shinya Murata |
Hirakata City Hospital
Department of Pediatrics
2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan
+81-72-847-2821
wildwind1980@live.jp
1st name | |
Middle name | |
Last name | Shinya Murata |
Hirakata City Hospital
Department of Pediatrics
2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan
+81-72-847-2821
wildwind1980@live.jp
Department of Pediatrics, Hirakata City Hospital
2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan
Tel: +81-72-847-2821; Fax: +81-72-847-2825
Department of Pediatrics, Hirakata City Hospital
2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan
Tel: +81-72-847-2821; Fax: +81-72-847-2825
Other
NO
2018 | Year | 01 | Month | 01 | Day |
Published
Completed
2015 | Year | 03 | Month | 01 | Day |
2015 | Year | 03 | Month | 01 | Day |
2017 | Year | 04 | Month | 30 | Day |
2018 | Year | 03 | Month | 30 | Day |
2018 | Year | 03 | Month | 30 | Day |
Pediatrics Oct 2018, e20181009; DOI: 10.1542/peds.2018-1009
2017 | Year | 07 | Month | 18 | Day |
2018 | Year | 10 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032366